Tianjin Key Laboratory of Retinal Functions and Diseases, Tianjin Branch of National Clinical Research Center for Ocular Disease, Eye Institute and School of Optometry, Tianjin Medical University Eye Hospital, 251 Fukang Road, Tianjin, 300384, China.
BMC Ophthalmol. 2022 Jul 23;22(1):317. doi: 10.1186/s12886-022-02532-6.
Usher syndrome (USH) is a leading disorder of deaf-blindness. The phenotypic and genetic heterogeneity of USH makes the diagnosis of this disorder difficult. However, diagnosis can be facilitated by employing molecular approaches, especially for diseases without pronounced pathognomonic symptoms. Therefore, this study aimed to reveal the genetic defects in five USH patients using clinical targeted exome sequencing (TES).
USH patients and their family members from five unrelated Chinese USH families were recruited and subjected to TES. Ophthalmic information was obtained for all patients to ensure a meaningful interpretation. The TES data were analysed using an established bioinformatics pipeline to identify causative mutations. Further verification by Sanger sequencing and cosegregation analysis were performed on available family members.
We identified genetic mutations in five USH patients using TES. Seven mutations, four of which were novel, were identified in the USH2A gene. One proband (F1-II-3) was found to have a homozygous mutation inherited from nonconsanguineous parents, and another proband (F5-III-1) was found to carry three USH2A gene mutations.
In conclusion, the study revealed the importance of TES in the clinical diagnosis of USH patients with variable phenotypes. The correlation between USH2A gene mutations and clinical phenotypes will help to refine the clinical diagnosis of USH.
先天性耳聋-色素性视网膜炎(Usher 综合征,USH)是一种主要的聋盲症。USH 的表型和遗传异质性使得该疾病的诊断变得困难。然而,通过采用分子方法,尤其是对于没有明显特征性症状的疾病,可以促进诊断。因此,本研究旨在通过临床靶向外显子组测序(TES)揭示五名 USH 患者的遗传缺陷。
从五个无血缘关系的中国 USH 家庭中招募了 USH 患者及其家庭成员,并进行 TES。对所有患者进行眼科信息采集,以确保有意义的解释。使用经过验证的生物信息学管道对 TES 数据进行分析,以识别致病突变。在可用的家庭成员中进行 Sanger 测序和共分离分析进一步验证。
我们通过 TES 在五名 USH 患者中发现了遗传突变。在 USH2A 基因中发现了七个突变,其中四个是新的。一个先证者(F1-II-3)被发现携带从非近亲父母遗传的纯合突变,另一个先证者(F5-III-1)携带三个 USH2A 基因突变。
总之,该研究表明 TES 在具有不同表型的 USH 患者的临床诊断中的重要性。USH2A 基因突变与临床表型之间的相关性有助于完善 USH 的临床诊断。